Trial Site Detail

 

Drug:	Nilotinib or Imatinib
Trial:	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

Pennsylvania Oncology Hematology Associates       Philadelphia , PA 19106 USA

 

Principal Investigator:	David Henry, MD
Contact:	Susan Kilcoyne 215-829-6306 ext 138 susankilcoyne@pennoncology.com
Activation Status of this Site:	Closed
Notes about this Site:
Pennsylvania Oncology Hematology Associates Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.